{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:21:12Z","timestamp":1785788472361,"version":"3.56.0"},"reference-count":45,"publisher":"Pan American Health Organization","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,21]]},"abstract":"<sec>\n<title>Objective.<\/title>\n<p>To estimate the burden of <italic>Chlamydia trachomatis<\/italic> (CT), <italic>Neisseria gonorrhoeae<\/italic> (NG), <italic>Treponema pallidum<\/italic> (TP), and human papillomavirus (HPV) infections among people aged 10 to 25 in Latin America and the Caribbean.<\/p>\n<\/sec>\n<sec>\n<title>Methods.<\/title>\n<p>The MEDLINE, EMBASE, and LILACS databases were searched, as well as documents from regional organizations or national health Institutions. Population-based studies that reported prevalence or incidence of CT, NG, TP, and HPV detected through confirmatory tests in adolescents and young people were included. Two reviewers independently selected studies and extracted data. The quality of studies was assessed using the Newcastle\u2013Ottawa Scale. Pooled estimators were calculated in cases where heterogeneity was &lt;70%; when not feasible, prevalence ranges were reported.<\/p>\n<\/sec>\n<sec>\n<title>Results.<\/title>\n<p>Out of a total of 3 583 references, 15 prevalence studies complied with the inclusion criteria. Due to substantial heterogeneity (&gt;70%), it was not possible to pool frequency estimators. Among the general population, the prevalence of CT infection ranged between 2.1% and 30.1% (9 studies, 5 670 participants); for NG, prevalence ranged between 0% and 2.9% (8 studies, 5 855 participants); for TP, prevalence varied between 0% and 0.7% (3 studies, 11 208 participants), and for HPV infection, prevalence ranged between 25.1% and 55.6% (8 studies, 3 831 participants).<\/p>\n<\/sec>\n<sec>\n<title>Conclusions.<\/title>\n<p>Reliable, population-based data on sexually transmitted infections (STIs) in adolescents and youth in Latin America and the Caribbean are limited. Additional studies are needed to better understand the burden of STIs in this population. However, given the substantial prevalence of STIs detected, countries need public health policies for prevention, early diagnosis, and treatment of STIs in young people.<\/p>\n<\/sec>","DOI":"10.26633\/rpsp.2022.73","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T16:10:11Z","timestamp":1655827811000},"page":"1","source":"Crossref","is-referenced-by-count":22,"title":["A systematic review of the prevalence of selected sexually transmitted infections in young people in Latin America"],"prefix":"10.26633","volume":"46","author":[{"given":"Mar\u00eda Teresa","family":"Vallejo-Ortega","sequence":"first","affiliation":[{"name":"Universidad Nacional de Colombia, Bogot\u00e1, Colombia"},{"name":"mtvallejoo@unal.edu.co"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernando","family":"Gait\u00e1n Duarte","sequence":"additional","affiliation":[{"name":"Universidad Nacional de Colombia, Bogot\u00e1, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maeve B.","family":"Mello","sequence":"additional","affiliation":[{"name":"Pan American Health Organization, Washington, D.C., United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Caffe","sequence":"additional","affiliation":[{"name":"Pan American Health Organization, Washington, D.C., United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy","family":"Perez","sequence":"additional","affiliation":[{"name":"Pan American Health Organization, Washington, D.C., United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11167","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97(8):548-62P.","DOI":"10.2471\/BLT.18.228486"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, et al. Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting. PLoS One. 2015;10(12):e0143304.","DOI":"10.1371\/journal.pone.0143304"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ. 2010;340:c1642.","DOI":"10.1136\/bmj.c1642"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Price MJ, Ades AE, Soldan K, Welton NJ, Macleod J, Simms I, et al. The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis. Health Technol Assess. 2016;20(22):1-250.","DOI":"10.3310\/hta20220"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Wijesooriya NS, Rochat RW, Kamb ML, Turlapati P, Temmerman M, Broutet N, et al. Global burden of maternal and congenital syphilis in 2008 and 2012: a health systems modelling study. Lancet Glob Health. 2016;4(8):e525-33.","DOI":"10.1016\/S2214-109X(16)30135-8"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Ng BE, Butler LM, Horvath T, Rutherford GW. Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection. Cochrane Database Syst Rev. 2011(3):CD001220.","DOI":"10.1002\/14651858.CD001220.pub3"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MCB, et al. Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2008. Sex Transm Dis. 2013;40(3).","DOI":"10.1097\/OLQ.0b013e318286bb53"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Forhan SE, Gottlieb SL, Sternberg MR, Xu F, Datta SD, McQuillan GM, et al. Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States. Pediatrics. 2009;124(6):1505-12.","DOI":"10.1542\/peds.2009-0674"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Aghaizu A, Reid F, Kerry S, Hay PE, Mallinson H, Jensen JS, et al. Frequency and risk factors for incident and redetected Chlamydia trachomatis infection in sexually active, young, multi-ethnic women: a community based cohort study. Sex Transm Infect. 2014;90(7):524-8.","DOI":"10.1136\/sextrans-2014-051607"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Calatrava M, Lopez-Del Burgo C, de Irala J. [Sexual risk factors among European young people]. Med Clin (Barc). 2012;138(12):534-40.","DOI":"10.1016\/j.medcli.2011.07.020"},{"key":"ref11","unstructured":"UNICEF, Oficina Regional para Am\u00e9rica Latina y el Caribe. Una aproximaci\u00f3n a la situaci\u00f3n de adolescentes y j\u00f3venes en Am\u00e9rica Latina y el Caribe a partir de evidencia cuantitativa reciente. [Electronic]. Panam\u00e1: UNICEF; 2015 [cited 2020]. Available from: https:\/\/www.unicef.org\/lac\/sites\/unicef.org.lac\/files\/2018-04\/UNICEF_Situacion_de_Adolescentes__y_Jovenes_en_LAC_junio2105.pdf."},{"key":"ref12","unstructured":"Workowski KA, Bolan GA, Centers for Disease C, Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1-137."},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Dubbink JH, Verweij SP, Struthers HE, Ouburg S, McIntyre JA, Morr\u00e9 SA, et al. Genital Chlamydia trachomatis and Neisseria gonorrhoeae infections among women in sub-Saharan Africa: A structured review. Int J STD AIDS. 2018;29(8):806-24.","DOI":"10.1177\/0956462418758224"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Kenyon C, Buyze J, Colebunders R. Classification of incidence and prevalence of certain sexually transmitted infections by world regions. Int J Infect Dis. 2014;18(Supplement C):73-80.","DOI":"10.1016\/j.ijid.2013.09.014"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Korenromp EL, R\u00edos C, Apolinar ALS, Caicedo S, Cuellar D, C\u00e1rdenas I, et al. Prevalence and incidence estimates for syphilis, chlamydia, gonorrhea, and congenital syphilis in Colombia, 1995-2016. Rev Panam Salud Publica. 2018;42:e118.","DOI":"10.26633\/RPSP.2018.118"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Modesti PA, Reboldi G, Cappuccio FP, Agyemang C, Remuzzi G, Rapi S, et al. Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-Analysis. PLoS One. 2016;11(1):e0147601.","DOI":"10.1371\/journal.pone.0147601"},{"key":"ref17","unstructured":"Wells G, Shea B, O\u2019Connel D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Electronic]. Ottawa, Canada: Ottawa Hospital Research Institute; 2019. Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"ref18","unstructured":"Lipsey MW, Wilson DB. Practical meta-analysis. Thousand Oaks, CA, US: Sage Publications, Inc; 2001. ix, 247-ix, p."},{"key":"ref19","unstructured":"Deeks J, Higgins JP, Altman D. Chapter 10: Analysing data and undertaking meta-analyses. 2020. In: Cochrane Handbook for Systematic Reviews of Interventions [Internet]. England: Cochrane. 6,1 (2020). Available from: https:\/\/training.cochrane.org\/handbook\/current\/chapter-10."},{"key":"ref20","unstructured":"Trinquart L, Chatellier G, editors. Meta-analysis of proportions: a review and comparison of statistical methods for combining results from several binomial trials. Bringing Evidence-Based Decision-Making to New Heights Abstracts of the 2010 Joint Colloquium of The Cochrane and Campbell Collaborations; 2010 2010 18-22 Oct; Keystone, United States: John Wiley & Sons; 2010."},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Clarke MA, Rodriguez AC, Gage JC, Herrero R, Hildesheim A, Wacholder S, et al. A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection. BMC Infect Dis. 2012;12:33.","DOI":"10.1186\/1471-2334-12-33"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"de Lima YA, Turchi MD, Fonseca ZC, Garcia FL, de Brito e Cardoso FA, da Guarda Reis MN, et al. Sexually transmitted bacterial infections among young women in Central Western Brazil. Int J Infect Dis. 2014;25:16-21.","DOI":"10.1016\/j.ijid.2014.03.1389"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Figueiredo Alves RR, Turchi MD, Santos LE, Guimaraes EM, Garcia MM, Seixas MS, et al. Prevalence, genotype profile and risk factors for multiple human papillomavirus cervical infection in unimmunized female adolescents in Goiania, Brazil: a community-based study. BMC Public Health. 2013;13:1041.","DOI":"10.1186\/1471-2458-13-1041"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Figueir\u00f3-Filho EA, Senefonte FR, Antunes Lopes AH, Oliveira de Morais O, Gon\u00e7alves Souza J\u00faniior V, Lemos Maia T, et al. Freq\u00fc\u00eancia das infec\u00e7\u00f5es pelo HIV-1, rub\u00e9ola, s\u00edfilis, toxoplasmose, citomegalov\u00edrus, herpes simples, hepatite B, hepatite C, doen\u00e7a de Chagas e HTLV I\/II em gestantes, do Estado de Mato Grosso do Sul. Rev Soc Bras Med Trop. 2007;40(2):181-7.","DOI":"10.1590\/S0037-86822007000200007"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Franceschi S, Smith JS, van den Brule A, Herrero R, Arslan A, Anh PT, et al. Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study. Sex Transm Dis. 2007;34(8):563-9.","DOI":"10.1097\/01.olq.0000258417.66619.0e"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Hernandez-Giron C, Smith JS, Lorincz A, Lazcano E, Hernandez-Avila M, Salmeron J. High-risk human papillomavirus detection and related risk factors among pregnant and nonpregnant women in Mexico. Sex Transm Dis. 2005;32(10):613-8.","DOI":"10.1097\/01.olq.0000179888.47309.db"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Matos E, Loria D, Amestoy GM, Herrera L, Prince MA, Moreno J, et al. Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study. Sex Transm Dis. 2003;30(8):593-9.","DOI":"10.1097\/01.OLQ.0000085181.25063.6C"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Miranda AE, Szwarcwald CL, Peres RL, Page-Shafer K. Prevalence and risk behaviors for chlamydial infection in a population-based study of female adolescents in Brazil. Sex Transm Dis. 2004;31(9):542-6.","DOI":"10.1097\/01.olq.0000137899.25542.75"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Paredes MC, G\u00f3mez YM, Torres AM, Fern\u00e1ndez M, Tovar MB. Prevalencia de infecciones por Chlamydia trachomatis y Neisseria gonorrhoeae en adolescentes de colegios de la provincia de Sabana Centro, Cundinamarca, Colombia. Biom\u00e9dica. 2015;35:314-24.","DOI":"10.7705\/biomedica.v35i3.2398"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Pinto VM, Szwarcwald CL, Baroni C, Stringari LL, Inocencio LA, Miranda AE. Chlamydia trachomatis prevalence and risk behaviors in parturient women aged 15 to 24 in Brazil. Sex Transm Dis. 2011;38(10):957-61.","DOI":"10.1097\/OLQ.0b013e31822037fc"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Santos Filho MV, Gurgel AP, Lobo CD, Freitas AC, Silva-Neto JC, Silva LA. Prevalence of human papillomavirus (HPV), distribution of HPV types, and risk factors for infection in HPV-positive women. Genet Mol Res. 2016;15(2).","DOI":"10.4238\/gmr.15028315"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Silveira MF, Sclowitz IK, Entiauspe LG, Mesenburg MA, Stauffert D, Bicca GL, et al. Chlamydia trachomatis infection in young pregnant women in Southern Brazil: a cross-sectional study. Cad Saude Publica. 2017;33(1):e00067415.","DOI":"10.1590\/0102-311x00067415"},{"key":"ref33","unstructured":"Tamayo-Acevedo LS, L\u00f3pez MI, Villegas A, Agudelo C, Arrubla M, Mu\u00f1oz Tamayo J. Determinantes de salud sexual e ITS en adolescentes rurales, escolarizados, Medell\u00edn, Colombia, 2008. Rev Salud Publica Medellin. 2011;5(Ene-Jun):7-24."},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Gabster A, Mohammed DY, Arteaga GB, Castillero O, Mojica N, Dyamond J, et al. Correlates of Sexually Transmitted Infections among Adolescents Attending Public High Schools, Panama, 2015. PLoS One. 2016;11(9):e0163391.","DOI":"10.1371\/journal.pone.0163391"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Valles X, Murga GB, Hernandez G, Sabido M, Chuy A, Lloveras B, et al. High prevalence of human papillomavirus infection in the female population of Guatemala. Int J Cancer. 2009;125(5):1161-7.","DOI":"10.1002\/ijc.24444"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Joseph Davey DL, Shull HI, Billings JD, Wang D, Adachi K, Klausner JD. Prevalence of Curable Sexually Transmitted Infections in Pregnant Women in Low- and Middle-Income Countries From 2010 to 2015: A Systematic Review. Sex Transm Dis. 2016;43(7):450-8.","DOI":"10.1097\/OLQ.0000000000000460"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Redmond SM, Alexander-Kisslig K, Woodhall SC, van den Broek IV, van Bergen J, Ward H, et al. Genital chlamydia prevalence in Europe and non-European high income countries: systematic review and meta-analysis. PLoS One. 2015;10(1):e0115753.","DOI":"10.1371\/journal.pone.0115753"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Lewis D, Newton DC, Guy RJ, Ali H, Chen MY, Fairley CK, et al. The prevalence of Chlamydia trachomatis infection in Australia: a systematic review and meta-analysis. BMC Infect Dis. 2012;12:113.","DOI":"10.1186\/1471-2334-12-113"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Hengel B, Jamil MS, Mein JK, Maher L, Kaldor JM, Guy RJ. Outreach for chlamydia and gonorrhoea screening: a systematic review of strategies and outcomes. BMC Public Health. 2013;13:1040.","DOI":"10.1186\/1471-2458-13-1040"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Chico RM, Mayaud P, Ariti C, Mabey D, Ronsmans C, Chandramohan D. Prevalence of malaria and sexually transmitted and reproductive tract infections in pregnancy in sub-Saharan Africa: a systematic review. JAMA. 2012;307(19):2079-86.","DOI":"10.1001\/jama.2012.3428"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Korenromp EL, Mahiane SG, Nagelkerke N, Taylor MM, Williams R, Chico RM, et al. Syphilis prevalence trends in adult women in 132 countries - estimations using the Spectrum Sexually Transmitted Infections model. Sci Rep. 2018;8(1):11503.","DOI":"10.1038\/s41598-018-29805-9"},{"key":"ref42","unstructured":"Departamento de Epidemiolog\u00eda, Ministerio de Salud Gobierno de Chile. Bolet\u00edn epidemiol\u00f3gico trimestral s\u00edfilis en todas sus formas (CIE10: A50,0 - A53,9). Semanas epidemiol\u00f3gicas 1 a 39 (1 de enero al 29 de septiembre) 2018."},{"key":"ref43","unstructured":"Ministerio de Salud, Direcci\u00f3n Vigilancia de Salud, Unidad de seguimiento de indicadores de Salud. Bolet\u00edn estad\u00edstico de enfermedades de declaraci\u00f3n obligatoria en Costa Rica del a\u00f1o 2015. Costa Rica: Ministerio de Salud Rep\u00fablica de Costa Rica; 2015."},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789-99.","DOI":"10.1086\/657321"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Smith JS, Gilbert PA, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of human papillomavirus infection in males: a global review. J Adolesc Health. 2011;48(6):540-52.","DOI":"10.1016\/j.jadohealth.2011.03.010"}],"container-title":["Revista Panamericana de Salud P\u00fablica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iris.paho.org\/bitstream\/handle\/10665.2\/56091\/v46e732022.pdf?sequence=1&isAllowed=y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T16:10:22Z","timestamp":1655827822000},"score":1,"resource":{"primary":{"URL":"https:\/\/iris.paho.org\/handle\/10665.2\/56091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":45,"alternative-id":["RPSP.2022.73"],"URL":"https:\/\/doi.org\/10.26633\/rpsp.2022.73","relation":{},"ISSN":["1020-4989","1680-5348"],"issn-type":[{"value":"1020-4989","type":"print"},{"value":"1680-5348","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,21]]}}}